From the Harvard Medical School, Boston, MA (Farid, Liimakka, and Parker), the Department of Orthopaedic Surgery, Division of Adult Reconstruction and Total Joint Arthroplasty, Brigham and Women's Hospital, Boston, MA (Liimakka, Chen, and Lange), the Department of Orthopaedic Surgery, Division of Foot and Ankle Surgery, Brigham and Women's Hospital, Boston, MA (Parker and Smith), and the Department of Orthopaedic Surgery, Hip & Knee Replacement Service, Massachusetts General Hospital, Boston, MA (Melnic).

Correspondence to Dr. Farid: [email protected]

Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.jaaos.org).

Smith or an immediate family member has received research or institutional support from Springer; serves as a board member, owner, officer, or committee member of AOFAS, Foot and Ankle International—editorial/governing board; Melnic or an immediate family member serves as a paid consultant to Smith & Nephew; Chen or an immediate family member has received royalties from JBJS, SLACK incorporated, Stryker, Taylor & Francis Group, and UpToDate; serves as a paid consultant to Adaptive Phage therapeutics, Avanos, BICMD, Convatec, Ethicon, GLG, Guidepoint, Heraeus, Irrimax, Osteal Therapeutics, Smith & Nephew, Stryker, and TrialSpark; has stock or stock options held in Hyalex, IlluminOss, Irrimax, and Osteal Therapeutics, Sonoran; serves as a board member, owner, officer, or committee member of AAOS, AJRR and AAHKS; has received research or institutional support from Adaptive Phage therapeutics, Elute, JBJS, Peptilogics, Sectra, SLACK incorporated, Taylor & Francis Group, and UpToDate; editorial/governing: Arthroplasty Today, Journal of Arthroplasty, Journal of Bone & Joint Infection, and JBJS. Lange or an immediate family member has received royalties from OnPoint Knee; serves as a board member, owner, officer, or committee member of AAHKS; serves as a paid consultant to Aesculap/B.Braun. Neither of the following authors nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Liimakka, Parker, and Farid.